Abstract

(1) Background: Chronic rhinosinusitis (CRS) represents a wide range of infectious-inflammatory processes affecting, simultaneously, the nose and paranasal sinuses mucosa. The paper presents outcomes of the investigation of CRS microbiological characteristics in a group of 32 patients. (2) Methods: The purulent samples were collected during functional endoscopic sinus surgery. Agar plates were incubated and examined. All types of colonies were identified using Matrix-Assisted Laser Desorption - Ionisation-Time of Flight Mass Spectrometry (MALDI-TOF MS). For scanning electron microscopy, samples were fixed and sputter-coated with 10 nm gold and analyzed using a scanning electron microscope. For transmission electron microscopy, samples were fixed, postfixed, and dehydrated. After polymerization, ultrathin sections were collected on carbon coated copper grids and analyzed with Jeol JEM1010 TEM. (3) Results: Positive microbiological diagnosis was obtained in 62.5% of cases. The most frequent species found are Staphylococcus aureus and Streptococcus constellatus subsp. pharyngis. Corynebacterium aurimucosum and Eggerthia catenaformis were unreported species in CRS until the present. Biofilm was evidenced in 43.7% of sinus mucosa samples. Ciliary disorientation, atrophy, and no ciliated cells were also identified. (4) Conclusion: The microbial factor—pathogen or opportunistic—is one of the most important pathological links in chronic rhinosinusitis. MALDI-TOF MS allows easily and quickly identification of germs.

Highlights

  • Chronic rhinosinusitis (CRS) is defined as inflammation of the nose and paranasal sinuses [1]

  • Ultrathin sections were collected on carbon coated copper grids and analyzed with Jeol JEM1010 Transmission Electron Microscopy (TEM). (3) Results: Positive microbiological diagnosis was obtained in 62.5% of cases

  • MBicorfoiblmiolwogaicsael vDidiaegnncoesdis in 43.7% (n = 14/32) of sinus mucosa samples (Figure 3), 15.6% (n = 5/32) of whPiocshitwiveeremfircormobpioaltoiegnictsalhdaviaignngoasinsefgraotmivepmuriucrloenbitoslaomgipcalel stewsta. s obtained in 62.5% of all cases (n = 20/32) (Table 1): CRSsNP/CRS with nasal polyps (CRSwNP)/odontogenic 40%/81.8%/69.2% (n = 2/9/9) of the cases of the respective subgroup

Read more

Summary

Introduction

Chronic rhinosinusitis (CRS) is defined as inflammation of the nose and paranasal sinuses [1]. CRS is considered one of the most widespread chronic diseases, representing a financial burden for health care systems [2]. European Position Paper on Rhinosinusitis and Nasal Polyps 2020 (EPOS) classification distributes CRS in primary and secondary, divided each into localized and diffuse [1]. In primary CRS, the disease is divided in type 2 or non-type 2 of inflammation (type 2 inflammation is characterized by cytokines IL-4, IL-5, and IL-13, activation and recruitment of eosinophils and mast cells). Secondary CRS can be localized (odontogenic, fungal ball, tumor) or diffuse. Primary CRS type 2 include CRS with nasal polyps (CRSwNP)—approximately 25–30% of cases [5]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call